Gefitinib response after acquisition of C797S following first-line osimertinib in EGFR L858R/E709K-mutated non-small cell lung cancer: A case report

Respiratory Investigation · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles